|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1983-1-27
|
|
pubmed:abstractText |
Activity levels of platelet monoamine oxidase (MAO) and plasma amine oxidase (PAO) were determined in eight chronic schizophrenic patients who had been treated with neuroleptic drugs for 3 months. The mean reduction in platelet MAO activity was 18.6%. The extent of decrease was statistically significant. The reduction in enzyme activity was unrelated to serum iron levels. PAO activity was unaltered. The implications for schizophrenia research are discussed.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0165-1781
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-87
|
|
pubmed:dateRevised |
2008-4-17
|
|
pubmed:meshHeading |
pubmed-meshheading:6128754-Adult,
pubmed-meshheading:6128754-Amine Oxidase (Copper-Containing),
pubmed-meshheading:6128754-Antipsychotic Agents,
pubmed-meshheading:6128754-Blood Platelets,
pubmed-meshheading:6128754-Chlorpromazine,
pubmed-meshheading:6128754-Female,
pubmed-meshheading:6128754-Fluphenazine,
pubmed-meshheading:6128754-Haloperidol,
pubmed-meshheading:6128754-Humans,
pubmed-meshheading:6128754-Male,
pubmed-meshheading:6128754-Monoamine Oxidase,
pubmed-meshheading:6128754-Oxidoreductases Acting on CH-NH Group Donors,
pubmed-meshheading:6128754-Schizophrenia
|
|
pubmed:year |
1982
|
|
pubmed:articleTitle |
Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
